Table 1. Restriction of HIV-1 by introduced Trim5α.

Source of Trim5α	HIV-1	G89V	CsA-treated*
Human	0.77 ± 0.03	0.77 ± 0.05	0.83 ± 0.03
AGM (CV-1)	0.10 ± 0.02	0.20 ± 0.04	0.28 ± 0.08
AGM (Vero)	0.06 ± 0.01	0.08 ± 0.02	0.11 ± 0.01
Rhesus	0.11 ± 0.03	0.14 ± 0.02	0.12 ± 0.01

Results shown are the mean of three experiments.

^*CsA, cyclosporine A. Ratio of Trim5α+ cells infected/Trim5α— cells infected